Pharma & Drug Safety

FDA Warning Letter to Nu Skin Enterprises for Drug Listing Violations

The FDA issued a warning letter to Nu Skin Enterprises for violations related to drug listing obligations under the Federal Food, Drug, and Cosmetic Act. The company failed to update manufacturing establishment information and has 61 inactivated drug listings. The FDA requires corrective action within 15 working days.

FDA Warning Letter to Tentamus India Private Limited

The FDA issued a warning letter to Tentamus India Private Limited for significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. The violations include the quality control unit failing to ensure CGMP compliance and the destruction or improper handling of analytical records.

FDA Warning Letter to Simtra BioPharma Solutions

The FDA issued a warning letter to Simtra BioPharma Solutions on March 3, 2026, citing significant violations of Current Good Manufacturing Practice (CGMP) regulations at their German drug manufacturing facility. The violations relate to inadequate controls in aseptic processing areas, leading to potential adulteration of drug products intended for the U.S. market.

Health Districts Urge Planning for Severe Weather

The Hampton & Peninsula Health Districts in Virginia are urging residents to plan for severe spring weather, including tornadoes, thunderstorms, and flooding. The notice provides safety tips and encourages participation in Severe Weather Awareness Week activities.

IntelliVue MX Patient Monitor System EC10 Recall

Health Canada has issued a Type II recall for the Philips IntelliVue MX Patient Monitor System-IntelliBridge Module EC10. The recall is due to a potential safety issue where the system may fail to alarm for 'No Device Data' INOP, affecting patient safety. Healthcare providers are advised to contact the manufacturer for additional information.

Glacial Gold Fuzzy Mango Recalled Due to Packaging and Labelling Issues

Nextleaf Labs Ltd. is recalling Glacial Gold – Anytime 1:1 Fuzzy Mango cannabis extract due to incorrect cannabinoid values on the label and packaging issues. Approximately 1998 units were sold in Alberta, British Columbia, and Saskatchewan. Consumers are advised to check if their product is affected and return it to the store.

FDA Early Alert: Erbe USA Cryoprobes Rupture Risk

The FDA issued an Early Alert regarding Erbe USA Flexible Cryoprobes due to a risk of rupture during activation, potentially causing injuries and hearing loss. Erbe USA has recalled affected lots and recommended discontinuing use.

Venlafaxine XR Recall

Health Canada has issued a Type II recall for VENLAFAXINE XR 75mg capsules due to dissolution testing being out of specification. Retailers are instructed to remove the affected product from shelves. Consumers should consult a healthcare provider before discontinuing use.

Worthy Crumb Pastry Co. Scones Recalled Due to Mould

The Canadian Food Inspection Agency has issued a recall for The Worthy Crumb Pastry Co. brand Cheddar and Chive Artisan Scones due to mould contamination. The product was distributed nationally, and consumers are advised not to use or distribute the affected product.

Choco Lake Diamond Twist Chocolate Recalled Due to Aflatoxin Contamination

The Canadian Food Inspection Agency has issued a recall for Choco Lake Diamond Twist brand Milk Chocolate with Kunafa Pistachio Paste Flavor due to aflatoxin contamination. The recall affects products distributed in Ontario, with specific lot codes and expiry dates identified.